Literature DB >> 31900881

Diagnosis and management of prolactinomas: current challenges.

Stephan Petersenn1, Andrea Giustina2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 31900881     DOI： 10.1007/s11102-019-01025-y

Source DB:  PubMed          Journal:  Pituitary        ISSN： 1386-341X            Impact factor:   4.107


× No keyword cloud information.
  20 in total

Review 1.  Aggressive prolactinomas: how to manage?

Authors:  Hélène Lasolle; Mirela Diana Ilie; Gérald Raverot
Journal:  Pituitary       Date:  2020-02       Impact factor: 4.107

Review 2.  Dopamine agonists in prolactinomas: when to withdraw?

Authors:  Pedro Souteiro; Sandra Belo; Davide Carvalho
Journal:  Pituitary       Date:  2020-02       Impact factor: 4.107

3.  Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data.

Authors:  Hilke Buurman; Wolfgang Saeger
Journal:  Eur J Endocrinol       Date:  2006-05       Impact factor: 6.664

Review 4.  Epidemiology and Management Challenges in Prolactinomas.

Authors:  Laurent Vroonen; Adrian F Daly; Albert Beckers
Journal:  Neuroendocrinology       Date:  2019-02-07       Impact factor: 4.914

5.  A Brazilian multicentre study evaluating pregnancies induced by cabergoline in patients harboring prolactinomas.

Authors:  B G Sant' Anna; N R C Musolino; M R Gadelha; C Marques; M Castro; P C L Elias; L Vilar; R Lyra; M R A Martins; A R P Quidute; J Abucham; D Nazato; H M Garmes; M L C Fontana; C L Boguszewski; C B Bueno; M A Czepielewski; E S Portes; V S Nunes-Nogueira; A Ribeiro-Oliveira; R P V Francisco; M D Bronstein; A Glezer
Journal:  Pituitary       Date:  2020-04       Impact factor: 4.107

Review 6.  Prolactinomas in males: any differences?

Authors:  Hadar Duskin-Bitan; Ilan Shimon
Journal:  Pituitary       Date:  2020-02       Impact factor: 4.107

7.  Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas.

Authors:  Beverly Mk Biller; Annamaria Colao; Stephan Petersenn; Vivien S Bonert; Marco Boscaro
Journal:  BMC Endocr Disord       Date:  2010-05-17       Impact factor: 2.763

Review 8.  Prolactinomas in pregnancy: considerations before conception and during pregnancy.

Authors:  Andrea Glezer; Marcello D Bronstein
Journal:  Pituitary       Date:  2020-02       Impact factor: 4.107

Review 9.  Magnetic resonance imaging in the management of prolactinomas; a review of the evidence.

Authors:  Elena V Varlamov; José Miguel Hinojosa-Amaya; Maria Fleseriu
Journal:  Pituitary       Date:  2019-10-28       Impact factor: 4.107

10.  A meta-analysis of the prevalence of cardiac valvulopathy in hyperprolactinemic patients treated with Cabergoline.

Authors:  C E Stiles; E T Tetteh-Wayoe; J Bestwick; R P Steeds; W M Drake
Journal:  J Clin Endocrinol Metab       Date:  2018-09-11       Impact factor: 5.958
View more
  5 in total

Review 1.  The optimal numerosity of the referral population of pituitary tumors centers of excellence (PTCOE): A surgical perspective.

Authors:  Pietro Mortini; Gianluca Nocera; Francesca Roncelli; Marco Losa; Anna Maria Formenti; Andrea Giustina
Journal:  Rev Endocr Metab Disord       Date:  2020-12       Impact factor: 6.514

2.  Prolactin immunoassay: does the high-dose hook effect still exist?

Authors:  Véronique Raverot; Pauline Perrin; Philippe Chanson; Emmanuel Jouanneau; Thierry Brue; Gérald Raverot
Journal:  Pituitary       Date:  2022-07-06       Impact factor: 3.599

Review 3.  Hyperprolactinemia and bone.

Authors:  Luigi di Filippo; Mauro Doga; Eugenia Resmini; Andrea Giustina
Journal:  Pituitary       Date:  2020-06       Impact factor: 4.107

Review 4.  Autophagy in normal pituitary and pituitary tumor cells and its potential role in the actions of somatostatin receptor ligands in acromegaly.

Authors:  Giovanni Tulipano; Andrea Giustina
Journal:  Rev Endocr Metab Disord       Date:  2021-04-05       Impact factor: 6.514

5.  Hypeprolactinemia: still an insidious diagnosis.

Authors:  Ludovica Aliberti; Irene Gagliardi; Romolo M Dorizzi; Stefano Pizzicotti; Marta Bondanelli; Maria Chiara Zatelli; Maria Rosaria Ambrosio
Journal:  Endocrine       Date:  2020-09-19       Impact factor: 3.633
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.